Cargando…

Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma

Clinical significance of 2,3-dioxygenase (IDO) has been studied in types of tumors, but the role that IDO played in gastric adenocarcinoma (GAC) is still unclear. Here, we aim to investigate the prognostic value of IDO expression in patients with GAC. We examined intratumoral IDO expression in retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hao, Shen, Zhenbin, Wang, Zhenglin, Wang, Xuefei, Zhang, Heng, Qin, Jing, Qin, Xinyu, Xu, Jiejie, Sun, Yihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758033/ https://www.ncbi.nlm.nih.gov/pubmed/26887337 http://dx.doi.org/10.1038/srep21319

Ejemplares similares

Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy
por: Liu, Hao, et al.
Publicado: (2016)

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
por: Wang, Zhenglin, et al.
Publicado: (2015)

Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy
por: Lin, Chao, et al.
Publicado: (2016)

A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients
por: LI, HE, et al.
Publicado: (2015)

Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy
por: Liu, Hao, et al.
Publicado: (2017)

Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection
por: Wang, Xuefei, et al.
Publicado: (2014)

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer
por: Wang, Hongshan, et al.
Publicado: (2016)

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
por: Shu, Ping, et al.
Publicado: (2017)

Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric Cancer
por: He, Hongyong, et al.
Publicado: (2013)

High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
por: Li, Ruochen, et al.
Publicado: (2016)

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer
por: He, Jiaqi, et al.
Publicado: (2017)

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis
por: Li, Ruochen, et al.
Publicado: (2020)

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO‐CLASSIC Study
por: Yu, Yiyi, et al.
Publicado: (2019)

Pattern of No. 12a lymph node metastasis in gastric cancer
por: Shu, Ping, et al.
Publicado: (2021)

A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer
por: Zhao, Junjie, et al.
Publicado: (2020)

High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy
por: Chen, Hao, et al.
Publicado: (2017)

Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer
por: Cao, Yifan, et al.
Publicado: (2016)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
por: Marttila, Saara, et al.
Publicado: (2011)

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial
por: Tang, Zhaoqing, et al.
Publicado: (2022)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer
por: Min, Cuili, et al.
Publicado: (2019)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients
por: Wang, Nan, et al.
Publicado: (2020)

IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases
por: Wu, Miaoqing, et al.
Publicado: (2023)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
por: Mitra, Devarati, et al.
Publicado: (2019)

IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
por: Jiao, Ruidi, et al.
Publicado: (2020)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020)

Using recursive partitioning approach to select tumor‐associated antigens in immunodiagnosis of gastric adenocarcinoma
por: Qin, Jiejie, et al.
Publicado: (2019)

Postoperative Adjuvant Radiotherapy for Patients with Gastric Adenocarcinoma
por: Lim, Do Hoon
Publicado: (2012)

Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer
por: Qin, Ruihuan, et al.
Publicado: (2017)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy
por: Peng, Peike, et al.
Publicado: (2016)

Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling
por: Qin, Ruihuan, et al.
Publicado: (2020)

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients
por: Jin, Kaifeng, et al.
Publicado: (2021)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Higher postoperative plasma EV PD-L1 predicts poor survival in patients with gastric cancer
por: Li, Gaopeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uhdjhp2bdp06ed272t3pf7l3hs